0:00:01 | my name is rubberness and i met him at holidays at the mayo clinic |
---|
0:00:05 | and it's my pleasure the present this video abstract |
---|
0:00:08 | and the manuscript written by rabbit emmanuel holly guy or and myself and voxal in |
---|
0:00:13 | the as an emerging therapy for model fibrosis |
---|
0:00:17 | model fibrosis is a chronic cologne all my lapel effort of ne of class |
---|
0:00:22 | it is a disease that affects individuals with wanna make early symptoms |
---|
0:00:27 | potential for site opinions |
---|
0:00:29 | the potential for progression look you'd milo talking and sadly frequently premature death from the |
---|
0:00:35 | onus |
---|
0:00:37 | in two thousand five it was of the discovery of achieve imitation in the model |
---|
0:00:41 | parallel for the veneer parzen half the genesis |
---|
0:00:44 | that of the jack to be six and seven f mutation |
---|
0:00:48 | the discovery that annotation lead to a rabbit effort to develop it is that were |
---|
0:00:53 | inhibitory of the jacks that pathway |
---|
0:00:56 | and hitters object one inject to have now been developed in tested in individuals with |
---|
0:01:02 | model fibrosis |
---|
0:01:03 | and the manuscript we discuss at least in development |
---|
0:01:08 | in early development eight in such as an s zero one eight o y two |
---|
0:01:12 | seventy four five four |
---|
0:01:14 | agents in face to face three testing set just as they are three o two |
---|
0:01:17 | five or three see what you three eight seven and procreate in |
---|
0:01:21 | these agents have demonstrated the ability |
---|
0:01:24 | for these inhibitors of jack to help to reduce plan a magazine these individuals and |
---|
0:01:30 | improve symptoms it is either maybe some variable benefits for anaemia related with the disease |
---|
0:01:36 | as demonstrated by c y t three eight seven and potentially poch written |
---|
0:01:41 | finally we going to the greatest detail in terms of the data for rock celine |
---|
0:01:46 | right solution of is now prove in the united states from the f d a |
---|
0:01:50 | as well as in europe in other countries |
---|
0:01:53 | based on the data from two randomized phase three trials |
---|
0:01:57 | these two trials called the comfort studies compared rocks a minute with either perceivable in |
---|
0:02:02 | the north american trial and versus best alternative therapy in the europeans trial |
---|
0:02:08 | these trials demonstrated that compared to these control on the rocks and then the |
---|
0:02:11 | was significantly superior for the reduction of smell mightily |
---|
0:02:15 | improving symptoms related with the disease improving quality of life |
---|
0:02:19 | and now improvement in survival compared to those control are |
---|
0:02:24 | in the manuscript we going to a discussion of the use approximate and then we |
---|
0:02:28 | talk about upcoming combination clinical trials |
---|
0:02:31 | as well as new drugs in development |
---|
0:02:33 | we also try to portray the futures keep up there before model fibrosis |
---|
0:02:38 | thanks to all of these scientific energy but into the disease particle e over these |
---|
0:02:42 | last five years is a much brighter future for patients with modified process |
---|
0:02:48 | thank |
---|